Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens
Elly Scheermeyer, Mark Harris, Ian Hughes, Patricia A Crock, Geoffrey Ambler, Charles F Verge, Phil Bergman, George Werther, Maria E Craig, Catherine S Choong, Peter SW Davies
Growth Hormone & IGF Research | CHURCHILL LIVINGSTONE | Published : 2017
Awarded by Pfizer
Awarded by Bond University Faculty Research Grant
We thank the following funding sources with respect to the establishment and maintenance of the of the PWS component of the PWSOZGROW database: Dr Elly Scheermeyer was a recipient of a Pfizer 2008 Investigator Initiated Research Grant AUS-GTR-08-001 and a Bond University 2009 Faculty Research Grant ZB02. The OZGROW Database is funded by a recurrent grant from the Australasian Paediatric Endocrine Group. We also thank Dr Yassmin Musthaffa, Dr Gary M Leong and all GH nurse coordinators for their assistance over time.